These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 16502593)

  • 1. Recommendations for the use of the 23-valent polysaccharide pneumococcal vaccine in adults: a Belgian consensus report.
    Peetermans WE; Van de Vyver N; Van Laethem Y; Van Damme P; Thiry N; Trefois P; Geerts P; Schetgen M; Peleman R; Swennen B; Verhaegen J
    Acta Clin Belg; 2005; 60(6):329-37. PubMed ID: 16502593
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Use of 13-valent pneumococcal conjugate vaccine and 23-valent pneumococcal polysaccharide vaccine for adults with immunocompromising conditions: recommendations of the Advisory Committee on Immunization Practices (ACIP).
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 2012 Oct; 61(40):816-9. PubMed ID: 23051612
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prevention of pneumococcal disease: an update on the Belgian Consensus Report.
    Peleman RA; Peetermans WE; Van Laethem Y; Bachez PG; Vanatoru J; Van Wassenhove K; Struelens MJ; Verhaegen JL
    Acta Clin Belg; 1999 Dec; 54(6):321-7. PubMed ID: 10686704
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cost-effectiveness of administering 13-valent pneumococcal conjugate vaccine in addition to 23-valent pneumococcal polysaccharide vaccine to adults with immunocompromising conditions.
    Cho BH; Stoecker C; Link-Gelles R; Moore MR
    Vaccine; 2013 Dec; 31(50):6011-21. PubMed ID: 24148572
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Regional advisory board position statement on optimal pneumococcal vaccination in adults. Update to 2011 consensus on adult pneumococcal disease: update on optimal pneumococcal vaccination in adults.
    Ludwig E; Unal S; Bogdan M; Chlíbek R; Ivanov Y; Kozlov R; Lode H; Mészner Z; Prymula R; Rahav G; Skoczyńska A; Solovic I; Sayiner A
    Cent Eur J Public Health; 2013 Dec; 21(4):233-6. PubMed ID: 24592732
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cost-effectiveness of pneumococcal conjugate vaccination in Croatia.
    Vučina VV; Filipović SK; Kožnjak N; Stamenić V; Clark AD; Mounaud B; Blau J; Hoestlandt C; Kaić B
    Vaccine; 2015 May; 33 Suppl 1():A209-18. PubMed ID: 25919163
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cost-effectiveness of conjugate pneumococcal vaccination in Singapore: comparing estimates for 7-valent, 10-valent, and 13-valent vaccines.
    Tyo KR; Rosen MM; Zeng W; Yap M; Pwee KH; Ang LW; Shepard DS
    Vaccine; 2011 Sep; 29(38):6686-94. PubMed ID: 21745516
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Cost effectiveness of vaccination against pneumococcal bacteremia in the elderly: the results in Belgium].
    De Graeve D; Verhaegen J; Ament A; Baltussen R
    Acta Clin Belg; 2000; 55(5):257-65. PubMed ID: 11109640
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cost-effectiveness of stockpiling 23-valent pneumococcal polysaccharide vaccine to prevent secondary pneumococcal infections among a high-risk population in the United States during an influenza pandemic.
    Dhankhar P; Grabenstein JD; O'Brien MA; Dasbach EJ
    Clin Ther; 2010 Aug; 32(8):1501-16. PubMed ID: 20728763
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Pneumococcal vaccine in adults: comparison of recommendations and discussion of its role].
    Borsu K; Krammisch H; Franckh M; Giet D
    Rev Med Liege; 2010 Apr; 65(4):191-8. PubMed ID: 20499821
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Belgian consensus on pneumococcal vaccine. Working Party on Pneumococcal Vaccine.
    Acta Clin Belg; 1996; 51(5):350-6. PubMed ID: 8950842
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cost-effectiveness of a 10- versus 13-valent pneumococcal conjugate vaccine in Denmark and Sweden.
    Klok RM; Lindkvist RM; Ekelund M; Farkouh RA; Strutton DR
    Clin Ther; 2013 Feb; 35(2):119-34. PubMed ID: 23312274
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cost effectiveness of pneumococcal vaccination among Dutch infants: economic analysis of the seven valent pneumococcal conjugated vaccine and forecast for the 10 valent and 13 valent vaccines.
    Rozenbaum MH; Sanders EA; van Hoek AJ; Jansen AG; van der Ende A; van den Dobbelsteen G; Rodenburg GD; Hak E; Postma MJ
    BMJ; 2010 Jun; 340():c2509. PubMed ID: 20519267
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cost effectiveness of adding 7-valent pneumococcal conjugate (PCV-7) vaccine to the Norwegian childhood vaccination program.
    Wisløff T; Abrahamsen TG; Bergsaker MA; Løvoll Ø; Møller P; Pedersen MK; Kristiansen IS
    Vaccine; 2006 Jul; 24(29-30):5690-9. PubMed ID: 16735083
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Vaccine Update: Recommendation for conjugate pneumococcal and pneumococcal polysaccharide vaccines in adults older than 65 years.
    Niemi SA; Foster SL; Hayney MS
    J Am Pharm Assoc (2003); 2015; 55(2):212, 214-5. PubMed ID: 25749266
    [No Abstract]   [Full Text] [Related]  

  • 16. Cost-effectiveness of pneumococcal conjugate vaccination in Georgia.
    Komakhidze T; Hoestlandt C; Dolakidze T; Shakhnazarova M; Chlikadze R; Kopaleishvili N; Goginashvili K; Kherkheulidze M; Clark AD; Blau J
    Vaccine; 2015 May; 33 Suppl 1():A219-26. PubMed ID: 25919165
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [23-valent pneumococcal vaccine. Statement of the Consultive Committee of Immunizations on behalf of the Chilean Infectious Diseases Society: February 2010].
    Ripoll M E; Valenzuela B MT; Vergara F R; Abarca V K; Muñoz M A; Jiménez de la Jara J; Pinto C ME; Luchsinger F V
    Rev Chilena Infectol; 2010 Apr; 27(2):133-7. PubMed ID: 20556313
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Recommendations for the prevention of Streptococcus pneumoniae infections in infants and children: use of 13-valent pneumococcal conjugate vaccine (PCV13) and pneumococcal polysaccharide vaccine (PPSV23).
    American Academy of Pediatrics Committee on Infectious Diseases
    Pediatrics; 2010 Jul; 126(1):186-90. PubMed ID: 20498180
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Call to action on pneumococcal disease: review of vaccination evidence and outcomes of webcast programs.
    Grogg SE; Schultz J
    J Am Osteopath Assoc; 2015 Jun; 115(6 Suppl):S6-25. PubMed ID: 26000904
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Licensure of a 13-valent pneumococcal conjugate vaccine (PCV13) and recommendations for use among children - Advisory Committee on Immunization Practices (ACIP), 2010.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 2010 Mar; 59(9):258-61. PubMed ID: 20224542
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.